Open AccessMetabolic and cardiovascular benefits with combination therapy of SGLT-2 inhibitors and GLP-1 receptor agonists in type 2 diabetes
Author(s) -
Awadhesh Kumar Singh,
Ritu Singh
Publication year - 2022
Publication title -
world journal of cardiology
Language(s) - English
Resource type - Journals
ISSN - 1949-8462
DOI - 10.4330/wjc.v14.i6.329
Subject(s) - medicine , blood pressure , placebo , adverse effect , combination therapy , type 2 diabetes , weight loss , hypoglycemia , heart failure , diabetes mellitus , randomized controlled trial , pharmacology , endocrinology , obesity , alternative medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom